Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
DOI
PMC
 |
Open Access Gold |
|
as soon as is submitted to ZB.
Erratum: Corrigendum: Interleukin-2-inducible T-cell kinase deficiency-new patients, new insight? (Frontiers in immunology (2018) 9 (979)).
Front. Immunol. 9, 2197:979 (2018)
[This corrects the article DOI: 10.3389/fimmu.2018.00979.].
Scopus
Cited By
Cited By
Altmetric
3
Annotations
Special Publikation
Hide on homepage
Publication type
Other: Correction, Addition
Keywords
Combined Immunodeficiency ; Epstein–barr Virus-related Malignancies ; Interleukin-2-inducible T-cell Kinase ; Lymphoproliferative Disorders ; Primary Immunodeficiency
Language
Publication Year
2018
HGF-reported in Year
2018
ISSN (print) / ISBN
1664-3224
e-ISSN
1664-3224
Journal
Frontiers in Immunology
Quellenangaben
Volume: 9,
Pages: 2197,
Article Number: 979
Publisher
Frontiers
Publishing Place
Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Reviewing status
Peer reviewed
Institute(s)
Research Unit Lung Repair and Regeneration (LRR)
Institute of Lung Health and Immunity (LHI)
Institute of Lung Health and Immunity (LHI)
POF-Topic(s)
30202 - Environmental Health
80000 - German Center for Lung Research
80000 - German Center for Lung Research
Research field(s)
Lung Research
PSP Element(s)
G-503100-005
G-501800-311
G-501800-311
WOS ID
WOS:000446065000001
Scopus ID
85054898198
PubMed ID
29867957
Erfassungsdatum
2018-10-12